PLANNING FOR PRECISION IN SURVIVAL STUDIES

被引:11
作者
BORENSTEIN, M [1 ]
机构
[1] BIOSTAT PROGRAMMING ASSOCIATES, TEANECK, NJ USA
关键词
SURVIVAL ANALYSIS; LIFE TABLE; CONFIDENCE INTERVALS; CONFIDENCE LIMITS; STATISTICAL POWER; STATISTICAL PRECISION; CLINICAL IMPORTANCE; BIOSTATISTICAL METHODS;
D O I
10.1016/0895-4356(94)90133-3
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
If the purpose of a clinical study is not only to test the null hypothesis but also to estimate the magnitude of the treatment effect, the study design should ensure not only that the study will have adequate power but also that it will enable the researcher to report the relevant parameters with an appropriate level of precision. This paper discusses the factors that control precision in survival studies and shows how a computer program may be used to address these issues. The program allows the user to systematically modify assumptions about the population (e.g. the magnitude of the hazard ratio or the attrition rate) and elements of the study design (e.g. sample size and trial duration), quickly identify the impact of these factors on the study's precision, and modify the study design accordingly. The program may also be used to compute power for a planned study, and confidence intervals for a completed study.
引用
收藏
页码:1277 / 1285
页数:9
相关论文
共 36 条
[1]   APPROXIMATE CONFIDENCE-INTERVALS FOR PROBABILITIES OF SURVIVAL AND QUANTILES IN LIFE-TABLE ANALYSIS [J].
ANDERSON, JR ;
BERNSTEIN, L ;
PIKE, MC .
BIOMETRICS, 1982, 38 (02) :407-416
[2]   A COMPARISON OF 2 SIMPLE HAZARD RATIO ESTIMATORS BASED ON THE LOGRANK TEST [J].
BERRY, G ;
KITCHIN, RM ;
MOCK, PA .
STATISTICS IN MEDICINE, 1991, 10 (05) :749-755
[3]  
BORENSTEIN M, 1994, IN PRESS CONTROLLED
[4]   SAMPLE SIZES FOR CONSTRUCTING CONFIDENCE-INTERVALS AND TESTING HYPOTHESES [J].
BRISTOL, DR .
STATISTICS IN MEDICINE, 1989, 8 (07) :803-811
[5]  
CUTLER SJ, 1958, J CHRON DIS, V8, P699
[6]   EFFECTIVE SAMPLE SIZES FOR CONFIDENCE-INTERVALS FOR SURVIVAL PROBABILITIES [J].
DOREY, FJ ;
KORN, EL .
STATISTICS IN MEDICINE, 1987, 6 (06) :679-687
[7]  
FEINSTEIN AR, 1976, CLIN PHARMACOL THER, V20, P617
[8]  
FEINSTEIN AR, 1975, CLIN PHARMACOL THER, V18, P491
[9]   IMPORTANCE OF BETA, TYPE-II ERROR AND SAMPLE-SIZE IN DESIGN AND INTERPRETATION OF RANDOMIZED CONTROL TRIAL - SURVEY OF 71 NEGATIVE TRIALS [J].
FREIMAN, JA ;
CHALMERS, TC ;
SMITH, H ;
KUEBLER, RR .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (13) :690-694
[10]   CONFIDENCE-INTERVALS RATHER THAN P-VALUES - ESTIMATION RATHER THAN HYPOTHESIS-TESTING [J].
GARDNER, MJ ;
ALTMAN, DG .
BMJ-BRITISH MEDICAL JOURNAL, 1986, 292 (6522) :746-750